Advertisement

Click here for more guidelines.

 
 




CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2006; 48:1800-1807, doi:10.1016/j.jacc.2006.03.070 (Published online 16 October 2006).
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2006.03.070v1
48/9/1800    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iribarren, C.
Right arrow Articles by Fortmann, S. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iribarren, C.
Right arrow Articles by Fortmann, S. P.

CLINICAL RESEARCH: METABOLIC SYNDROME

Metabolic Syndrome and Early-Onset Coronary Artery Disease

Is the Whole Greater Than Its Parts?

Carlos Iribarren, MD, MPH, PhD*,{dagger},*, Alan S. Go, MD*,{dagger}, Gail Husson, MPH, Med*, Stephen Sidney, MD, MPH*, Joan M. Fair, ANP, PhD{ddagger}, Thomas Quertermous, MD§, Mark A. Hlatky, MD§,|| and Stephen P. Fortmann, MD{ddagger}

* Kaiser Permanente Division of Research, Oakland, California
{dagger} Departments of Epidemiology, Biostatistics, and Medicine, University of California, San Francisco, California
{ddagger} Stanford Prevention Research Center
§ Division of Cardiovascular Medicine
|| Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California

Manuscript received December 19, 2005; revised manuscript received February 10, 2006, accepted March 16, 2006.

* Reprint requests and correspondence: Dr. Carlos Iribarren, Research Scientist, Kaiser Permanente, Division of Research, 2000 Broadway, Oakland, California 94612. (Email: cgi{at}dor.kaiser.org).

OBJECTIVES: We sought to examine the association between the metabolic syndrome (MetS) (defined both by the 2001 National Cholesterol Educational Program Adult Treatment Panel III [ATP-III] definition and the American Heart Association/National Heart, Lung and Blood Institute [AHA/NHLBI] revision incorporating the lower threshold for impaired fasting glucose [IFG]) and early-onset coronary artery disease (CAD).

BACKGROUND: The impact of MetS on premature CAD has not been studied extensively. Lowering the threshold to define the IFG component (from 110 to 100 mg/dl) and the value of the syndrome as a whole versus its individual components are subjects of intense debate.

METHODS: We performed a case-control study with 393 early-onset CAD subjects (acute myocardial infarction, angina with ≥50% stenosis, or coronary revascularization) in men under age 46 years or women under age 56 years and 393 control subjects individually matched for gender, age, and race/ethnicity.

RESULTS: By conditional logistic regression, presence of ATP-III MetS without diabetes (adjusted odds ratio [adj-OR] 4.9; 95% confidence interval [CI] 3.4 to 8.0) and with diabetes (adj-OR 8.0, 95% CI 4.39 to 14.6) was a strong independent determinant of early-onset CAD. Using the AHA/NHLBI revision, these ORs became slightly stronger. However, neither definition of MetS remained significantly associated with early-onset CAD in multivariate models adjusting for individual components.

CONCLUSIONS: The presence of MetS imparts a high risk of early-onset clinical CAD, but the prognostic information associated with the syndrome is not greater than the sum of its parts.

Abbreviations and Acronyms
  ADA = American Diabetes Association
  ADVANCE = Atherosclerotic Disease, Vascular Function, and Genetic Epidemiology
  AHA/NHLBI = American Heart Association/National Heart, Lung, and Blood Institute
  CAD = coronary artery disease
  CARDIA = Coronary Artery Risk Development in Young Adults
  HOMA-IR = homeostasis model assessment of insulin resistance
  IFG = impaired fasting glucose
  KPNC = Kaiser Permanente of Northern California
  MetS = metabolic syndrome
  NCEP-ATP-III = National Cholesterol Educational Program Adult Treatment Panel III




This article has been cited by other articles:


Home page
European Journal of Cardiovascular Prevention & RehabilitationHome page
B. Lubiszewska, M. Kruk, G. Broda, E. Ksiezycka, W. Piotrowski, P. Kurjata, T. Zielinski, and R. Ploski
The impact of early menopause on risk of coronary artery disease (PREmature Coronary Artery Disease In Women - PRECADIW case-control study)
European Journal of Cardiovascular Prevention & Rehabilitation, February 1, 2012; 19(1): 95 - 101.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
T. Zeller, S. Blankenberg, and P. Diemert
Genomewide Association Studies in Cardiovascular Disease--An Update 2011
Clin. Chem., January 1, 2012; 58(1): 92 - 103.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. J. Maron, W. E. Boden, J. A. Spertus, P. M. Hartigan, G. B. J. Mancini, S. P. Sedlis, W. J. Kostuk, B. R. Chaitman, L. J. Shaw, D. S. Berman, et al.
Impact of Metabolic Syndrome and Diabetes on Prognosis and Outcomes With Early Percutaneous Coronary Intervention in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) Trial
J. Am. Coll. Cardiol., July 5, 2011; 58(2): 131 - 137.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. T. Kraja, D. Vaidya, J. S. Pankow, M. O. Goodarzi, T. L. Assimes, I. J. Kullo, U. Sovio, R. A. Mathias, Y. V. Sun, N. Franceschini, et al.
A Bivariate Genome-Wide Approach to Metabolic Syndrome: STAMPEED Consortium
Diabetes, April 1, 2011; 60(4): 1329 - 1339.
[Abstract] [Full Text] [PDF]


Home page
J. Epidemiol. Community HealthHome page
F. Hadaegh, A. Zabetian, D. Khalili, M. Safarkhani, W. P. T. James, and F. Azizi
A new approach to compare the predictive power of metabolic syndrome defined by a joint interim statement versus its components for incident cardiovascular disease in Middle East Caucasian residents in Tehran
J Epidemiol Community Health, November 4, 2010; (2010) jech.2010.117697v1.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Mente and S. Anand
Reply
J. Am. Coll. Cardiol., October 12, 2010; 56(16): 1356 - 1356.
[Full Text] [PDF]


Home page
Diabetes CareHome page
A. K. Gupta, B. Dahlof, P. S. Sever, N. R. Poulter, and for the Anglo-Scandinavian Cardiac Outcomes Trial-
Metabolic Syndrome, Independent of Its Components, Is a Risk Factor for Stroke and Death But Not for Coronary Heart Disease Among Hypertensive Patients in the ASCOT-BPLA
Diabetes Care, July 1, 2010; 33(7): 1647 - 1651.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Mente, S. Yusuf, S. Islam, M. J. McQueen, S. Tanomsup, C. L. Onen, S. Rangarajan, H. C. Gerstein, S. S. Anand, and for the INTERHEART Investigators
Metabolic Syndrome and Risk of Acute Myocardial Infarction: A Case-Control Study of 26,903 Subjects From 52 Countries
J. Am. Coll. Cardiol., May 25, 2010; 55(21): 2390 - 2398.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
J. S. Lee, S.-I. Cho, and H. S. Park
Metabolic syndrome and cancer-related mortality among Korean men and women
Ann. Onc., March 1, 2010; 21(3): 640 - 645.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
H G Raterman, I C van Eijk, A E Voskuyl, M J L Peters, B A C Dijkmans, V P van Halm, S Simsek, W F Lems, and M T Nurmohamed
The metabolic syndrome is amplified in hypothyroid rheumatoid arthritis patients: a cross-sectional study
Ann Rheum Dis, January 1, 2010; 69(01): 39 - 42.
[Abstract] [Full Text] [PDF]


Home page
Chronic IllnessHome page
Y. S. Khader, B. Khasawneh, A. K. Daoud, and M. Khatatbeh
The association between metabolic syndrome and coronary artery disease in Jordan
Chronic Illness, December 1, 2009; 5(4): 235 - 242.
[Abstract] [PDF]


Home page
Hum Mol GenetHome page
T. L. Assimes, J. W. Knowles, A. Basu, C. Iribarren, A. Southwick, H. Tang, D. Absher, J. Li, J. M. Fair, G. D. Rubin, et al.
Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic ADVANCE study
Hum. Mol. Genet., August 1, 2008; 17(15): 2320 - 2328.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
J. R. Burt, C. Iribarren, J. M. Fair, L. C. Norton, M. Mahbouba, G. D. Rubin, M. A. Hlatky, A. S. Go, S. P. Fortmann, and for the Atherosclerotic Disease, Vascular Function
Incidental Findings on Cardiac Multidetector Row Computed Tomography Among Healthy Older Adults: Prevalence and Clinical Correlates
Arch Intern Med, April 14, 2008; 168(7): 756 - 761.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
D. Ardigo, T. L. Assimes, S. P. Fortmann, A. S. Go, M. Hlatky, E. Hytopoulos, C. Iribarren, P. S. Tsao, R. Tabibiazar, T. Quertermous, et al.
Circulating chemokines accurately identify individuals with clinically significant atherosclerotic heart disease
Physiol Genomics, November 14, 2007; 31(3): 402 - 409.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Inchiostro, G. P. Fadini, S. V. de Kreutzenberg, N. Citroni, and A. Avogaro
Is the Metabolic Syndrome a Cardiovascular Risk Factor Beyond Its Specific Components?
J. Am. Coll. Cardiol., June 26, 2007; 49(25): 2465 - 2465.
[Full Text] [PDF]


Home page
Eur Heart JHome page
J. Wang, S. Ruotsalainen, L. Moilanen, P. Lepisto, M. Laakso, and J. Kuusisto
The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns
Eur. Heart J., April 1, 2007; 28(7): 857 - 864.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement